Abstract:BACKGROUND:The pathogenesis of severe hepatitis B remains unknown. Reports have indicated that hepatitis B virus (HBV) mutations are important factors in the pathogenesis of this disease. This study was to investigate the genetic heterogeneity of HBV strains from serum samples of patients with fulminant hepatitis B.METHODS:Full-length HBV genomes from 4 patients with severe hepatitis B were cloned and sequenced to observe mutations in every open reading-frame (ORF). Serum samples of another 25 patients with severe hepatitis B, 30 patients with chronic hepatitis B, and 25 HBV carriers were collected for sequencing and comparison of mutations in preS2, preC and core promoter regions.RESULTS:Of 4 HBV full-length genome sequences, 3 had a G to A mutation at nucleotide A1896 in the preC region and 1 had double mutations of T1762-A1764 in the core promoter region. The 4 sequences showed mutations in the known B or T cell epitopes of the preS2 and C regions. For the other 3 groups, more mutations were seen in the preS2 region in the HBV isolates from the patients with severe hepatitis B than those from the patients with chronic hepatitis B and HBV carriers (P<0.01). There was a significant difference of mutations in the T cell epitope region of preS2 between the patients with severe hepatitis B and those with chronic hepatitis B or HBV carriers (P<0.01). In the preC and core promoter regions, the mutation frequencies of T1653 and C1753 were 48.0% and 24.0% respectively in the patients with severe hepatitis B, but none of these mutations were observed in the patients with chronic hepatitis B group or HBV carriers (P<0.01). The mutation frequency of T1762-A1764 was 76.0% in the patients with severe hepatitis B, 40.0% in the patients with chronic hepatitis B (P<0.01), and 16.0% in the HBV carriers (P<0.01). There was a significant difference in A1896 mutation between the patients with severe hepatitis B and the patients with chronic hepatitis B (P<0.05) or the HBV carriers (P<0.05).CONCLUSION:Our observations suggest that the accumulation and persistence of high frequency mutations or complex mutations may be associated with the development and deterioration of HBV infection.

A3G‐induced mutations show a low prevalence and exhibit plus‐strand regional distribution in hepatitis B virus DNA from patients with non‐hepatocellular carcinoma (HCC) and HCC

APOBEC3-induced mutation of the hepatitis virus B DNA genome occurs during its viral RNA reverse transcription into (−)-DNA

Association of Human APOBEC3 Cytidine Deaminases with the Generation of Hepatitis Virus B X Antigen Mutants and Hepatocellular Carcinoma

Association Between Polymorphisms of Theapobec3ggene and Chronic Hepatitis B Viral Infection and Hepatitis B Virus-Related Hepatocellular Carcinoma

Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis

The Mechanism of APOBEC3B in Hepatitis B Virus Infection and HBV Related Hepatocellular Carcinoma Progression, Therapeutic and Prognostic Potential

Evidence of Associations of APOBEC3B Gene Deletion with Susceptibility to Persistent HBV Infection and Hepatocellular Carcinoma.

Associations Between the Single Nucleotide Polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and Chronic Hepatitis B Progression and Hepatocellular Carcinoma in a Chinese Population

Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

Comparison Study on the Complete Sequence of Hepatitis B Virus Identifies New Mutations in Core Gene Associated with Hepatocellular Carcinoma

Clinical and virological implications of A1846T and C1913A/G mutations of hepatitis B virus genome in severe liver diseases

Expressions of APOBEC3G in liver tissues of chronic hepatitis B and hepatocellular carcinoma and its significance

N-terminal and C-terminal Cytosine Deaminase Domain of APOBEC3G Inhibit Hepatitis B Virus Replication

Uracil DNA Glycosylase Counteracts APOBEC3G-Induced Hypermutation of Hepatitis B Viral Genomes: Excision Repair of Covalently Closed Circular DNA

[Inhibitory Effect of a HBV Vector Plasmid Expressing A3C on HBV Replication].

Young Investigator Session

APOBEC3G Directly Binds Hepatitis B Virus Core Protein in Cell and Cell Free Systems

The Associations Between Polymorphisms of APOBEC3G and Different Outcomes of Persistent HBV Infection

Study on the Complete Sequence of Hepatitis B s Identifies New Mutations in Core Gene Associated with B & P atocellular Carcinoma

T3098C and T53C Mutations of HBV Genotype C is Associated with HBV Infection Progress

[Expression and Subcellular Localization of APOBEC3G in Peripheral Blood Mononuclear Cells and Liver Tissues of Chronic HBV Patients].